Information about Rtlc
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0840.135.311

VAT liability
Yes
Established
11-10-2011
Last balance sheet year
2024
Company size
Small 0 FTE
Commercial name
Novozymatic
Principal activity
Manufacture of medicaments
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Rtlc

2024 2023 2022 2021
Profit/Loss 3,736 -97 % 123,015 115 % 57,245 -74 % 218,044
Equity 423,530 1 % 419,794 41 % 296,779 24 % 239,533
Gross margin 5,311 -96 % 124,436 107 % 60,043 -74 % 232,348

Publications from Rtlc

Date Publication
28-09-2020 Modification Legal Form - Denomination - Registered Office - Resignations, Appointments (FR)
23-04-2018 Registered Office - Capital, Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (FR)
20-06-2016 Resignations, Appointments (FR)
13-10-2011 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Rtlc?
The VAT number of Rtlc is BE 0840.135.311.
Wat is the PEPPOL ID of Rtlc?
There is no information available about the PEPPOL ID of Rtlc or the company is not yet registered on the PEPPOL network.
When was Rtlc founded?
Rtlc was founded on 11-10-2011.
What is the address of Rtlc?
The current registered office of Rtlc is located at Avenue des Croix de Guerre 149/13, 1120 Bruxelles.
When was the last time Rtlc filed their annual financial statements?
The most recent financial statements of Rtlc were filed on 03-09-2025.
How many employees does Rtlc have?
There are currently no employees working at Rtlc or no workforce information is available.
What is the annual turnover of Rtlc?
At the time of its most recent financial statements, Rtlc did not publish any turnover figures. Rtlc reported a gross margin of €5,311.20.